Oramed Pharmaceuticals Inc.
ORMP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 8/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$19,103 | $5,088 | -$37,764 | -$22,989 |
| Dep. & Amort. | $193 | $196 | $58 | $77 |
| Deferred Tax | $0 | $0 | $0 | -$689 |
| Stock-Based Comp. | $4,053 | $4,212 | $11,509 | $2,695 |
| Change in WC | $3,200 | -$2,696 | -$943 | -$1,315 |
| Other Non-Cash | $3,245 | -$17,095 | -$778 | $1,040 |
| Operating Cash Flow | -$8,412 | -$10,295 | -$27,918 | -$21,181 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$18 | -$254 | -$496 | -$375 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$55,757 | -$190,919 | -$154,405 | -$53,822 |
| Inv. Sales/Matur. | $161,657 | $118,135 | $185,086 | $30,434 |
| Other Inv. Act. | -$65 | $0 | $26 | -$1 |
| Investing Cash Flow | $105,817 | -$73,038 | $30,211 | -$23,764 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$49,550 | $49,550 | $0 | $0 |
| Stock Issued | $0 | $2,428 | $11,500 | $79,983 |
| Stock Repurch. | -$2,484 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2 | $0 | -$721 | $22,909 |
| Financing Cash Flow | -$52,036 | $51,978 | $10,779 | $102,892 |
| Forex Effect | -$4 | -$54 | -$64 | $2 |
| Net Chg. in Cash | $45,365 | -$31,409 | $13,008 | $57,949 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9,055 | $40,464 | $27,456 | $19,296 |
| End Cash | $54,420 | $9,055 | $40,464 | $77,245 |
| Free Cash Flow | -$8,430 | -$10,549 | -$28,414 | -$21,556 |